-
Content Validation of the Patient Attainment Scale-Essential Tremor (PAS-ET): A Novel Patient-Reported Outcome Measure Assessing Patient-Level Perceptions of the Importance, Current Function and Definitions of Meaningful Improvement in Tremor-Related...
Mar 10, 2025, 14:00 PM -
State of Inclusion of Patient-Centered Endpoints in Duchenne Muscular Dystrophy (DMD) Clinical Trials
Mar 10, 2025, 14:00 PM -
Emerging Trends in AI Applications: Shaping Pharmacoepidemiology and Health Technology Assessments
Mar 10, 2025, 14:00 PM -
Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies
Mar 10, 2025, 14:00 PM -
Real-World Evidence in FDA Approvals for Labeling Extension of Drugs and Biologics
Mar 10, 2025, 14:00 PM -
Association Between Event-Free/Distant Relapse-Free Survival and Overall Survival in Patients With Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer
Mar 10, 2025, 14:00 PM -
JAV-RARAS: Evaluation of Adherence to Clinical Protocol and Therapeutic Guidelines (PCDT) for Mucopolysaccharidosis Type 2 (MPS2) at Codajás Polyclinic - An Analysis of the Value-Based Care Journey
Mar 10, 2025, 14:00 PM -
Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs
Mar 10, 2025, 14:00 PM -
Da Vinci Robotic-Assisted Surgery: 5 years of Health Technology Assessment Trends and Recommendations
Mar 10, 2025, 14:00 PM -
Relationship between Genetic Polymorphisms and Clinical Parameters in Mexican Postmenopausal Women: A Study on Cardiovascular Health
Mar 10, 2025, 14:00 PM -
Enhancing Early-Phase Trial Outcomes: The Value of Patient-Reported Treatment Tolerability
Mar 10, 2025, 14:00 PM -
A Model-Based Cost-Effectiveness Analysis of Anamorelin and Olanzapine in NSCLC Cachexia Treatment in Japan
Mar 10, 2025, 14:00 PM -
Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study
Mar 10, 2025, 14:00 PM -
A Health Economic Evaluation of an Artificial Intelligence-Assisted Prescription Review System in a Real-World Setting in China
Mar 10, 2025, 14:00 PM -
Quality of Life Assessment of Patients Undergoing Hip Replacement Surgery in the Public and Private Healthcare Systems
Mar 10, 2025, 14:00 PM -
Evaluating Generative AI in Replicating Health Economic Models: A Case Study on Ulcerative Colitis
Mar 10, 2025, 14:00 PM -
Exploring Oral Skeletal Muscle Relaxant Therapy in Adult Poststroke Patients in the US
Mar 10, 2025, 14:00 PM -
Impact of Circulating Tumor DNA (ctDNA) Burden Among Patients with Head and Neck Dquamous Cell Carcinoma (HNSCC) - A RWE Analysis
Mar 10, 2025, 14:00 PM -
Other Similar Measures? – How Different Really Are QALYs From Life Years, Health Years in Total, and Equal Value Life Years?
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab in 1L Recurrent/Metastatic Head and Neck Squamous Cell Cancer (R/M HNSCC) in Brazil
Mar 10, 2025, 14:00 PM
